This work reports the synthesis and pharmacological and electrophysiological evaluation of new <i>N</i>-methyl-d-aspartic acid receptor (NMDAR) channel blocking antagonists featuring polycyclic scaffolds. Changes in the chemical structure modulate the potency and voltage dependence of inhibition. Two of the new antagonists display properties comparable to those of memantine, a clinically approved NMDAR antagonist
The N-methyl-D-aspartate (NMDA) receptor consists of a recog-nition site for NMDA, a cation-selectiv...
Alzheimer’s disease (AD) is a progressive neurodegenerative disease that causes problems with ...
The NMDA receptor is a heteromeric ligand-gated ion channel in the central nervous system (CNS). The...
Background: The N-methyl-D-aspartate (NMDA) receptor is a complex ligand gated, voltage dependent io...
The novel compound 2-amino-4,5-(1,2-cyclohexyl)-7-phospho-noheptanoic acid (NPC 1 2626) was evaluate...
Electrophysiological techniques can be used to great effect to help determine the mechanism of actio...
The biological activities of six symmetrically substituted 2-methoxy-benzyl polymethylene tetraamine...
Using the patch-clamp technique, we studied the effect of two novel adamantane derivatives, N-[2-(3,...
Excessive Ca2+ currents via N-methyl-D-aspartate receptors (NMDARs) have been implicated in many dis...
A series of novel tricyclic pyrido-phthalazine-dione derivatives was tested for antagonistic effects...
NMDA is the excitatory amino acid receptor subtype that is most thoroughly studied. It is an ionotro...
N-methyl-D-aspartate (NMDA) receptors are a subtype of ionotropic glutamate receptors, which mediate...
The two diastereomeric pairs of acidic amino acids 5-(2-amino-2-carboxyethyl)-4,5-dihydroisoxazole-3...
The clinical potential of most N-methyl-D-Aspartate (NMDA) receptor antagonists as neuroprotectants ...
Pharmacological inhibition of NMDA receptor activity by ketamine is accompanied by pyschotomimetic s...
The N-methyl-D-aspartate (NMDA) receptor consists of a recog-nition site for NMDA, a cation-selectiv...
Alzheimer’s disease (AD) is a progressive neurodegenerative disease that causes problems with ...
The NMDA receptor is a heteromeric ligand-gated ion channel in the central nervous system (CNS). The...
Background: The N-methyl-D-aspartate (NMDA) receptor is a complex ligand gated, voltage dependent io...
The novel compound 2-amino-4,5-(1,2-cyclohexyl)-7-phospho-noheptanoic acid (NPC 1 2626) was evaluate...
Electrophysiological techniques can be used to great effect to help determine the mechanism of actio...
The biological activities of six symmetrically substituted 2-methoxy-benzyl polymethylene tetraamine...
Using the patch-clamp technique, we studied the effect of two novel adamantane derivatives, N-[2-(3,...
Excessive Ca2+ currents via N-methyl-D-aspartate receptors (NMDARs) have been implicated in many dis...
A series of novel tricyclic pyrido-phthalazine-dione derivatives was tested for antagonistic effects...
NMDA is the excitatory amino acid receptor subtype that is most thoroughly studied. It is an ionotro...
N-methyl-D-aspartate (NMDA) receptors are a subtype of ionotropic glutamate receptors, which mediate...
The two diastereomeric pairs of acidic amino acids 5-(2-amino-2-carboxyethyl)-4,5-dihydroisoxazole-3...
The clinical potential of most N-methyl-D-Aspartate (NMDA) receptor antagonists as neuroprotectants ...
Pharmacological inhibition of NMDA receptor activity by ketamine is accompanied by pyschotomimetic s...
The N-methyl-D-aspartate (NMDA) receptor consists of a recog-nition site for NMDA, a cation-selectiv...
Alzheimer’s disease (AD) is a progressive neurodegenerative disease that causes problems with ...
The NMDA receptor is a heteromeric ligand-gated ion channel in the central nervous system (CNS). The...